Finance

Lists
EUFA3:BVMF
Eurofarma Laboratorios SA
0.00%
(0.00) 1D
Oct 19, 9:52:20 AM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for EUFA3...
Volume
0.00
P/E ratio
0.00
EPS
R$0.81
Shares outstanding
989.21M
No. of employees
13K
Volume
0.00
P/E ratio
0.00
EPS
R$0.81
Shares outstanding
989.21M
No. of employees
13K
News stories
From web sources and news partners
About Eurofarma Laboratorios SA
CEO-
Employees13K
Founded1966
Headquarters-
Sector-
Previous reportsAll values in BRL
Loading Previous Earnings...
Revenue
Net income
All values in BRL
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.21B
3.50B
3.00B
3.12B
Cost of goods sold
1.08B
1.23B
1.00B
1.10B
Cost of revenue
1.08B
1.23B
1.00B
1.10B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.64B
1.65B
1.45B
1.66B
Operating expense
1.41B
1.89B
1.44B
1.57B
Total operating expenses
2.49B
3.13B
2.45B
2.67B
Operating income
717.30M
369.02M
548.34M
447.23M
Other non operating income
-
-291.62M
-131.20M
-
EBT including unusual items
403.56M
222.94M
227.03M
165.30M
EBT excluding unusual items
403.56M
-14.18M
223.48M
165.30M
Income tax expense
42.17M
127.40M
13.93M
5.55M
Effective tax rate
10.45%
57.15%
6.14%
3.36%
Other operating expenses
-240.46M
236.01M
-6.00M
-86.87M
Net income
357.84M
83.76M
203.38M
156.55M
Net profit margin
11.15%
2.40%
6.79%
5.02%
Earnings per share
-
-
-
-
Interest and investment income
175.66M
70.58M
42.86M
112.90M
Interest expense
-491.31M
-311.45M
-320.23M
-392.40M
Net interest expenses
-315.65M
-240.87M
-277.38M
-279.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
825.36M
401.57M
636.18M
569.64M
Gain or loss from assets sale
16.33M
-91.19M
-
10.50M
AI content may include mistakes. Learn more
Google apps